SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-087005
Filing Date
2023-11-14
Accepted
2023-11-14 16:30:53
Documents
95
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_avalon.htm   iXBRL 10-Q 2233092
2 AVALON GLOBOCARE CORP. AMENDED AND RESTATED 2020 STOCK INCENTIVE PLAN f10q0923ex10-12_avalon.htm EX-10.12 139669
3 CERTIFICATION f10q0923ex31-1_avalon.htm EX-31.1 11259
4 CERTIFICATION f10q0923ex31-2_avalon.htm EX-31.2 11531
5 CERTIFICATION f10q0923ex32-1_avalon.htm EX-32.1 4272
6 CERTIFICATION f10q0923ex32-2_avalon.htm EX-32.2 4397
  Complete submission text file 0001213900-23-087005.txt   10568560

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE avco-20230930.xsd EX-101.SCH 102554
8 XBRL CALCULATION FILE avco-20230930_cal.xml EX-101.CAL 53063
9 XBRL DEFINITION FILE avco-20230930_def.xml EX-101.DEF 473481
10 XBRL LABEL FILE avco-20230930_lab.xml EX-101.LAB 854097
11 XBRL PRESENTATION FILE avco-20230930_pre.xml EX-101.PRE 487189
89 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_avalon_htm.xml XML 1486222
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38728 | Film No.: 231407009
SIC: 2836 Biological Products, (No Diagnostic Substances)